Identification of dual-targeted Mycobacterium tuberculosis aminoacyl-tRNA synthetase inhibitors using machine learning

Sunday, 15 January 2023

Recently, the article dedicated to the development of novel antituberculosis agents targeting aminoacyl-tRNA synthetases using machine learning approach has been...

Identification of novel small-molecular inhibitors of Staphylococcus aureus sortase A using hybrid virtual screening

Tuesday, 19 April 2022

Recently, the article dedicated to the development of Staphylococcus aureus sortase A inhibitors using the methods of molecular docking and pharmacophore screening has been...

Identification of novel antistaphylococcal hit compounds targeting sortase A

Wednesday, 24 November 2021

Recently, the article dedicated to the development of Staphylococcus aureus sortase A inhibitors possessing antibacterial activity toward multidrug resistant strains has been...

Discovery of novel antituberculosis agents among 3-phenyl-5-(1-phenyl-1H-[1,2,3]triazol-4-yl)-[1,2,4]oxadiazole derivatives targeting aminoacyl-tRNA synthetases

Friday, 16 April 2021

Recently, the article dedicated to the development of novel antituberculosis agents among 3-phenyl-5-(1-phenyl-1H-[1,2,3]triazol-4-yl)-[1,2,4]oxadiazoles targeting aminoacyl-tRNA...

News and Events

Identification of dual-targeted Mycobacterium tuberculosis aminoacyl-tRNA synthetase inhibitors using machine learning

Identification of novel small-molecular inhibitors of Staphylococcus aureus sortase A using hybrid virtual screening

Identification of novel antistaphylococcal hit compounds targeting sortase A

Discovery of novel antituberculosis agents among 3-phenyl-5-(1-phenyl-1H-[1,2,3]triazol-4-yl)-[1,2,4]oxadiazole derivatives targeting aminoacyl-tRNA synthetases

Our research:

CK2 Inhibitors

ASK1 Inhibitors

FGFR1 Inhibitors

Molecular Design

Fluorescent Probes